全文获取类型
收费全文 | 2286篇 |
免费 | 52篇 |
国内免费 | 11篇 |
专业分类
耳鼻咽喉 | 3篇 |
儿科学 | 22篇 |
妇产科学 | 10篇 |
基础医学 | 198篇 |
口腔科学 | 33篇 |
临床医学 | 35篇 |
内科学 | 173篇 |
皮肤病学 | 3篇 |
神经病学 | 278篇 |
特种医学 | 6篇 |
外科学 | 40篇 |
综合类 | 48篇 |
预防医学 | 98篇 |
眼科学 | 1篇 |
药学 | 1374篇 |
中国医学 | 4篇 |
肿瘤学 | 23篇 |
出版年
2022年 | 10篇 |
2021年 | 22篇 |
2020年 | 27篇 |
2019年 | 32篇 |
2018年 | 36篇 |
2017年 | 31篇 |
2016年 | 33篇 |
2015年 | 41篇 |
2014年 | 74篇 |
2013年 | 146篇 |
2012年 | 77篇 |
2011年 | 123篇 |
2010年 | 95篇 |
2009年 | 120篇 |
2008年 | 147篇 |
2007年 | 110篇 |
2006年 | 120篇 |
2005年 | 76篇 |
2004年 | 74篇 |
2003年 | 69篇 |
2002年 | 41篇 |
2001年 | 57篇 |
2000年 | 63篇 |
1999年 | 55篇 |
1998年 | 48篇 |
1997年 | 36篇 |
1996年 | 36篇 |
1995年 | 52篇 |
1994年 | 40篇 |
1993年 | 37篇 |
1992年 | 48篇 |
1991年 | 32篇 |
1990年 | 19篇 |
1989年 | 23篇 |
1988年 | 25篇 |
1987年 | 24篇 |
1986年 | 19篇 |
1985年 | 28篇 |
1984年 | 29篇 |
1983年 | 16篇 |
1982年 | 23篇 |
1981年 | 15篇 |
1980年 | 11篇 |
1979年 | 12篇 |
1978年 | 11篇 |
1975年 | 8篇 |
1974年 | 11篇 |
1973年 | 17篇 |
1972年 | 9篇 |
1969年 | 8篇 |
排序方式: 共有2349条查询结果,搜索用时 15 毫秒
1.
2.
The effect of prenatal exposure to nicotine on nicotine-induced analgesia was studied in rats. The analgesic effect of a single dose of nicotine (1 mg/kg SC) was measured by the tail-flick technique, and two subsequent studies were carried out. In the first study, 7-month-old male rats, born to dams chronically treated with nicotine during pregnancy (NIC), exhibited prolonged nicotine-induced analgesia compared to matched controls. The second study was designed to explore whether rats prenatally exposed to nicotine (NIC rats) are born with an increased sensitivity to nicotine and whether there is any sex difference. The analgesic effect of nicotine was tested on control and NIC rats of both sexes once a month from 2 to 7 months of age. At an early age, male but not female NIC rats, exhibited shorter analgesic responses to nicotine than did the matched controls. With increasing age, however, the duration of nicotine analgesia began to be prolonged in NIC rats of both sexes. Significant differences between control and NIC rats were found at the age of 6 and 7 months, in both sexes. Thus, rats prenatally exposed to nicotine are not born with an increased sensitivity to the analgesic effect of a single dose of nicotine. This phenomenon develops later, during the course of life, independently of gender. 相似文献
3.
Smoking and raven IQ 总被引:1,自引:0,他引:1
Nicotine has recently been shown to enhance measures of information processing speed including the decision time (DT) component of simple and choice reaction time and the string length measure of evoked potential waveform complexity. Both (DT and string length) have been previously demonstrated to correlate with performance on standard intelligence tests (IQ). We therefore hypothesised that nicotine is acting to improve intellectual performance on the elementary information processing correlates of IQ. In the current experiment we tested this hypothesis using the Raven Advanced Progressive Matrices (APM) test. APM scores were significantly higher in the smoking session compared to the non-smoking session, suggesting that nicotine acts to enhance physiological processes underlying performance on intellectual tasks. 相似文献
4.
Kathleen M Grant Stephanie Sinclair Kelley Lynette M Smith Sangeeta Agrawal James R Meyer Debra J Romberger 《Alcohol》2007,41(5):381-391
This is a double-blind placebo-controlled study of sustained-release bupropion as a smoking cessation aid in alcoholics undergoing treatment for their alcoholism. Participants (N=58) were enrolled within 1 week of entry into alcohol treatment from community and Veterans Affairs Substance Use Disorder programs. All participants received nicotine patch and were invited to attend a smoking cessation lecture and group. Cigarette smoking and alcohol outcomes were measured at 6 months. Bupropion when added to nicotine patch did not improve smoking outcomes. One third of participants on bupropion reported discontinuing the drug during weeks 1-4. Participants reported cigarette outcomes with nicotine patch that are similar to those seen in the general population. All study participants significantly reduced cigarette use. Comorbid affective disorder or antipersonality disorder did not affect outcomes. Alcohol outcomes were improved in those who discontinued cigarettes. 相似文献
5.
Circling behavior in honey bees 总被引:1,自引:0,他引:1
Unilateral microinjections of gamma-aminobutyric acid (GABA), acetylcholine (ACh) and related substances into central parts of the brain of the honey bee elicit a quantifiable circling behavior. GABA (40 nl, 10(-2) M, muscimol (40 nl, 10(-4) M) and flaxedil (10(-3) M, 40 nl) induce contralateral circling whilst ACh (40 nl, 10(-2) M), nicotine (40 nl, 10(-4) M) and picrotoxin (40 nl, 10(-3) M) induce ipsilateral circling if injected in the proximity of the alpha-lobe (50-100 microns) of the of the mushroom body. Mechanical lesions of the pedunculus induce ipsilateral circling. This can be reversed by ipsilateral injections of GABA and flaxedil. Intracellular recordings demonstrate a hyperpolarizing effect of GABA and a depolarising effect of ACh on individual neurons in this region. These results suggest that circling behavior in the bee is controlled by the balance of GABA in the alpha-lobes and mediated by acetylcholinergic neurons. 相似文献
6.
The pharmacology of synthetic
- and
-epibatidine, an alkaloid originally characterized from frog skin, were studied in different behavioral tests in mice and rats. The two enantiomers have potent antinociceptive activity in mice using the tail-flick test, with an ED50 of 6.1 and 6.6 μg/kg for
- and
-epibatidine respectively. Epibatidine enantiomers were 200 × more potent than
-nicotine as an antinociceptive agent in mice after s.c. administration. Their analgesic effect was blocked by mecamylamine but not naloxone, an opiate antagonist. Both
- and
-epibatidine have high affinity (Ki 54.7 and 55.0 pM, respectively) for [3H]nicotine binding site in rat brain. In addition, they reduced mice locomotor activity and body temperature in a dose-dependent manner. In rats trained with nicotine (0.4 mg/kg), epibatidine enantiomers engendered nicotine-like responding in a dose-related manner with an ED50 of 1.00 and 0.93 μg/kg for
and
, respectively. The discriminative effect of
- and
-epibatidine in rats was blocked by mecamylamine but not by hexamethonium. As in binding results, there was no significant enantioselectivity for these effects in our study. 相似文献
7.
G. Sutherland M. A. H. Russell J. Stapleton C. Feyerabend O. Ferno 《Psychopharmacology》1992,108(4):512-518
Plasma nicotine concentrations following administration by two types of nasal nicotine spray were compared in ten subjects. Absorption was particularly rapid during the first 2.5 min, the average rise in blood nicotine concentrations during this time being 8.6 ng/ml for the two products, followed by a small further rise to an average peak increase of 10.5 ng/ml 5 min after the dose of 2 mg nicotine base (mean 27.8 micrograms/kg). Despite a four-fold Cmax variation between subjects, the levels of individual subjects were fairly consistent across the two products. There were no significant differences between the two products in blood nicotine concentrations or cardiovascular responses, and the correlation between the AUCs from the two products was 0.68 (P = 0.01). Eight subjects reported subjective feelings of light-headedness or slight dizziness, which are not typical after slower absorption from nicotine gum or skin patches. Blood nicotine levels within the smoking range were soon built up with repeated doses, even in the subject with the least efficient nasal absorption. In a second study of ad libitum use under clinical conditions both products appeared sufficiently acceptable for therapeutic use as an aid to smoking cessation. There was no tendency to escalate to excessive use over 4 weeks, and blood nicotine concentrations in nine subjects averaged only 44% of their prior smoking levels. Only one subject had levels equivalent to prior smoking and possible reasons why this was not more common are discussed. 相似文献
8.
Jody Tanabe Jason R Tregellas Laura F Martin Robert Freedman 《Neuropsychopharmacology》2006,59(8):754-761
BACKGROUND: Abnormal smooth pursuit eye movement (SPEM) in schizophrenic patients is a well known phenomenon, but the neurophysiological mechanisms underlying the deficit are unknown. Nicotine temporarily improves SPEM and has been associated with reduced hippocampal hemodynamic activity in schizophrenics. Nicotine's effect on brain activity in control subjects performing SPEM has not been studied. The purpose of this work was to determine if nicotine differentially affects brain activity in schizophrenic and control subjects during pursuit eye tracking. METHODS: 16 subjects with schizophrenia and 16 control subjects underwent functional MR imaging during SPEM after receiving placebo or nicotine gum. Four brain regions were analyzed for main effects of group, drug, and interactions: hippocampus, cingulate gyrus, frontal eye fields, and area MT. RESULTS: Nicotine reduced hippocampal activity in both groups, but the effect was greater in control subjects. A group by drug interaction was observed in the anterior cingulate gyrus, where nicotine decreased activity in control subjects and increased activity in schizophrenic subjects. There were no significant effects of group, drug, or interactions in frontal eye fields or area MT. CONCLUSIONS: Nicotine may improve SPEM performance in people with schizophrenia through cholinergic stimulation of the hippocampus and cingulate gyrus. Potential mechanisms include improved inhibitory function and attention. 相似文献
9.
S. G. Gourlay N. L. Benowitz A. Forbes J. J. McNeil 《European journal of clinical pharmacology》1997,51(5):407-414
Objective: Interindividual variability in plasma concentrations of nicotine and its proximate metabolite, cotinine, is considerable
during smoking and transdermal nicotine treatment, even among individuals taking in nominally similar doses of nicotine. This
report explores the determinants of this variability and the utility of baseline (smoking) plasma concentrations to predict
concentrations during transdermal nicotine treatment.
Methods: Data were analysed from a smoking cessation study (n = 466), and from a pharmacokinetic study (n = 12). Multiple regression models examined the relationships of plasma concentrations to individual characteristics such
as smoking pattern, absorbed dose of nicotine, and pharmacokinetic parameters.
Results: Plasma concentrations of nicotine and cotinine were highly variable in both studies. Indirect estimates of plasma clearance
(baseline plasma concentration divided by cigarettes per day) together with other factors could account for 18 to 33% of the
variability during transdermal nicotine treatment in the smoking cessation study. In contrast, 75 to 99% was accounted for
by direct measurements of plasma clearances and systemic dose of nicotine in the pharmacokinetic study.
Conclusion: Plasma concentrations of nicotine and cotinine during transdermal nicotine treatment are poorly predicted by clinical history
or baseline plasma concentrations. This is a result of inadequate characterisation of highly variable individual pharmacokinetic
parameters and absorbed dose of nicotine. Considering the interindividual variability of plasma nicotine and cotinine concentrations
together with the lack of clinical end-points for transdermal nicotine dosing, it seems logical to investigate the utility
of a therapeutic drug monitoring approach for transdermal nicotine treatment – particularly for high dose regimens (> 22 mg
per 24 hours).
Received: 7 May 1996 / Accepted in revised form: 21 August 1996 相似文献
10.
Nicotine discrimination and self-administration in humans as a function of smoking status 总被引:2,自引:2,他引:0
Nicotine’s discriminative stimulus effects may be critical to understanding reinforcement of tobacco smoking. It is not known
whether regular nicotine exposure produces tolerance or sensitivity to these effects. In this study, male and female smokers
(n = 11) and never-smokers (n = 10) were trained to discriminate 20 μg/kg nicotine by nasal spray from placebo (0) on day 1. On day 2, both groups were
tested on generalization of this discrimination across intermittent presentations of 0, 3, 6, 12, and 20 μg/kg nicotine in
random order. Quantitative and quantal behavioral discrimination tasks, used in previous research, were employed. On day 3,
subjects were instructed to self-administer sprays from the 20 μg/kg nicotine versus 0 bottles in a concurrent-choice procedure.
All but one subject (female smoker) learned reliably to discriminate 20 μg/kg nicotine from placebo (≥ 80% correct) on day 1. Nicotine-appropriate responding on day 2 was attenuated in smokers versus never-smokers at 20 μg/kg
on the quantitative task and at 12 μg/kg on the quantal task, suggesting tolerance. There was no difference in responding
at other doses. Smokers also showed attenuated responses on the subjective measure of “head rush”, which was associated with
discrimination responding in both groups. Nicotine self-administration was significantly greater in smokers versus never-smokers,
who self-administered nicotine below chance levels, and was inversely related to discrimination behavior in never-smokers
but unrelated in smokers. Women smokers showed less change in nicotine-appropriate responding across generalization doses,
reported less confidence in discriminating training doses during acquisition on day 1, and tended to self-administer less
nicotine on day 3. These results indicate that smokers may become tolerant to the discriminative stimulus effects of nicotine,
perhaps promoting increased use.
Received: 1 October 1996/Final version: 28 January 1997 相似文献